ÂÜÀòÂÒÂ×

Prashant B. Rao is an accomplished professional with extensive experience in alliance management, strategic partnerships, and program leadership across the biotechnology and pharmaceutical industries. Currently serving as Head of Alliance Management at Cytokinetics, Prashant B. Rao drives development and commercialization efforts for aficamten and omecamtiv mecarbil in collaboration with Ji Xing Pharmaceuticals Limited. Previous roles include Executive Director at Esperion, where leadership focused on strategic commercialization partnerships, and key positions at Amgen emphasizing oncology biosimilar launches and corporate development. With a solid educational background that includes an MBA from the University of Chicago Booth School of Business and advanced degrees in Mechanical Engineering from Carnegie Mellon University and the University of Mumbai, Prashant B. Rao combines technical expertise with strategic acumen.